ATLAS Science & Biotech Stocks
Menu
Atlas · Symbols · Science & Biotech Stocks

Atlas World · Science and biotech intelligence

Track discovery, trials and regulatory evidence.

Follow the research path from scientific platform to disclosed milestone, source record and unresolved risk.

Search 414 company files Open Atlas Desk
Research theme
BIO
Company files
414
Research path
Evidence-led
Live research lensBIO
01Scientific platform

Resolve the research area, modality and company role before interpreting milestones.

01 · Research path

From category signal to evidence.

Biotech, life-sciences, genomics, laboratory, research and scientific instrument companies. Atlas keeps the identity, source context and retained research handoff connected.

  1. 01Scientific platform

    Resolve the research area, modality and company role before interpreting milestones.

  2. 02Milestone evidence

    Inspect trial, regulatory and partnership updates against attributable source material.

  3. 03Uncertainty map

    Keep evidence limits, catalyst context and unanswered questions visible in the file.

02 · Material change

What changed across Atlas.

Pulse surfaces source-backed changes from the current public research window. Open a file to inspect the evidence before drawing a conclusion.

Atlas Pulse

Source-backed changes today

Open daily pulse
UNHmaterial_change UnitedHealth Group Incorporated Since the previous file: new catalyst evidence: Next 10-K segment split: The company’s 2025 10-K disclosed Optum Health, Optum Insight,... 14 sources XYZmaterial_change Block Inc. Since the previous file: new catalyst evidence: Block’s next quarterly 10-Q filing, due in early August 2026, will show whether operating leverage... 14 sources WMTmaterial_change Walmart Inc. Since the previous file: new catalyst evidence: Walmart’s next earnings release (Q2 FY27) could include updated segment disclosures or guidance,... 14 sources WDCmaterial_change WESTERN DIGITAL CORP Since the previous file: new catalyst evidence: The 10-Q period ending 2026-04-03 shows $3.34B of revenue from contracts with customers, giving the... 14 sources VODmaterial_change Vodafone Since the previous file: new catalyst evidence: FY26 preliminary results confirm 5.4% organic service revenue growth and 4.5% adjusted EBITDAaL... 12 sources UBERmaterial_change Uber Technologies Inc. Since the previous file: new catalyst evidence: Release of detailed segment-level profitability for mobility, delivery, and freight in the next 10-Q... 14 sources TSEMmaterial_change TOWER SEMICONDUCTOR LTD Since the previous file: updated source coverage, new catalyst evidence: METI strategic capacity subsidy announcement: a quantified grant or... 12 sources TLSmaterial_change TELOS CORP Since the previous file: updated source coverage, new catalyst evidence: The Hawaii Department of Transportation’s renewal of the aviation worker... 14 sources

20 public Pulse items - 2026-08-12. Research only, not investment advice.

03 · Company research lanes

Move through the listed-company world.

Regional and thematic lanes share one evidence contract while keeping the operating context unique to each category.